Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease

NCT01598740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: CLP
DRUG: Spironolactone

Sponsor

Sorbent Therapeutics